A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. [electronic resource]
Producer: 20131217Description: 783-7 p. digitalISSN:- 1523-5866
- Adolescent
- Adult
- Antineoplastic Agents -- therapeutic use
- Arsenic Trioxide
- Arsenicals -- therapeutic use
- Astrocytoma -- mortality
- Brain Stem Neoplasms -- mortality
- Chemoradiotherapy
- Child
- Child, Preschool
- Dose Fractionation, Radiation
- Female
- Follow-Up Studies
- Humans
- Male
- Neoplasm Grading
- Oxides -- therapeutic use
- Prognosis
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.